{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:16:33Z","timestamp":1790727393815,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.aprim.2021.102231","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T15:08:59Z","timestamp":1642432139000},"page":"102231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Tratamiento de la escabiosis"],"prefix":"10.1016","volume":"54","author":[{"given":"Daniel","family":"Morgado-Carrasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Piquero-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Podlipnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2021.102231_bib0165","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jdv.14351","article-title":"European guideline for the management of scabies","volume":"31","author":"Salavastru","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.aprim.2021.102231_bib0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaad.2019.05.109","article-title":"Part I - Ectoparasites: Scabies","volume":"82","author":"Thomas","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aprim.2021.102231_bib0175","first-page":"15","article-title":"Increase of scabies in Germany and development of resistant mites? Evidence and consequences","volume":"1","author":"Sunderk\u00f6tter","year":"2019","journal-title":"J Dtsch Dermatol Ges."},{"key":"10.1016\/j.aprim.2021.102231_bib0180","article-title":"\u00abLoss of efficacy of topical 5% permethrin for treating scabies: An Austrian single-center study\u00bb","author":"Meyersburg","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.aprim.2021.102231_bib0185","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/1346-8138.13896","article-title":"Guideline for the diagnosis and treatment of scabies in Japan (third edition): Executive Committee of Guideline for the Diagnosis and Treatment of Scabies","volume":"44","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.aprim.2021.102231_bib0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaad.2019.11.069","article-title":"How to eliminate scabies parasites from fomites: A high-throughput ex vivo experimental study","volume":"83","author":"Bernigaud","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aprim.2021.102231_bib0195","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/ddg.13130","article-title":"S1 guidelines on the diagnosis and treatment of scabies - short version","volume":"14","author":"Sunderk\u00f6tter","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.aprim.2021.102231_bib0200","unstructured":"CDC - Scabies - Resources for Health Professionals - Medications 2019. [consultado 7 Jul 2021] Disponible en: https:\/\/www.cdc.gov\/parasites\/scabies\/health_professionals\/meds.html"},{"key":"10.1016\/j.aprim.2021.102231_bib0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1610-0387.2006.05941.x","article-title":"Treatment of scabies with 5% permethrin cream: Results of a German multicenter study","volume":"4","author":"Hamm","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.aprim.2021.102231_bib0210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jamadermatol.2019.0279","article-title":"Evaluation of Ivermectin vs Permethrin for Treating Scabies-Summary of a Cochrane Review","volume":"155","author":"Rosumeck","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.aprim.2021.102231_bib0215","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1111\/jdv.17339","article-title":"Is Scabies becoming less sensitive to permethrin therapy?","volume":"35","author":"Mazzatenta","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.aprim.2021.102231_bib0220","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17538","article-title":"Scabies is becoming less sensitive to permethrin therapy","author":"Balestri","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.aprim.2021.102231_bib0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0035-9203(00)90454-1","article-title":"Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis","volume":"94","author":"Walton","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.aprim.2021.102231_bib0230","first-page":"554","article-title":"Application errors associated with topical treatment of scabies: An observational study","volume":"18","author":"Nemecek","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.aprim.2021.102231_bib0235","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jaad.2019.01.004","article-title":"Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials","volume":"80","author":"Thadanipon","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aprim.2021.102231_bib0240","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/bjd.18369","article-title":"Ivermectin safety in infants and children under 15kg treated for scabies: A multicentric observational study","volume":"182","author":"Levy","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aprim.2021.102231_bib0245","doi-asserted-by":"crossref","first-page":"e0004389","DOI":"10.1371\/journal.pntd.0004389","article-title":"Prospects for Moxidectin as a New Oral Treatment for Human Scabies","volume":"10","author":"Mounsey","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.aprim.2021.102231_bib0250","doi-asserted-by":"crossref","first-page":"e13746","DOI":"10.1111\/dth.13746","article-title":"Scabies: A comprehensive review and current perspectives","volume":"33","author":"Arora","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.aprim.2021.102231_bib0255","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1471-0528.2007.01290.x","article-title":"Safety of benzyl benzoate lotion and permethrin in pregnancy: A retrospective matched cohort study","volume":"114","author":"Mytton","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.aprim.2021.102231_bib0260","doi-asserted-by":"crossref","first-page":"e0008929","DOI":"10.1371\/journal.pntd.0008929","article-title":"Scabies-infested pregnant women: A critical therapeutic challenge","volume":"15","author":"Weill","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.aprim.2021.102231_bib0265","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/S2214-109X(19)30453-X","article-title":"Safety of oral ivermectin during pregnancy: A systematic review and meta-analysis","volume":"8","author":"Nicolas","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.aprim.2021.102231_bib0270","doi-asserted-by":"crossref","first-page":"e0009144","DOI":"10.1371\/journal.pntd.0009144","article-title":"A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?","volume":"15","author":"Jittamala","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.aprim.2021.102231_bib0275","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/archdischild-2017-314505","article-title":"Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15kg?","volume":"103","author":"Wilkins","year":"2018","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.aprim.2021.102231_bib0280","first-page":"597","article-title":"Topical scabies therapy with permethrin is effective and well tolerated in infants younger than two months","volume":"17","author":"Hoffmann","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.aprim.2021.102231_bib0285","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/ajd.13654","article-title":"A narrative review of the roles of topical permethrin and oral ivermectin in the management of infantile scabies","volume":"62","author":"Lobo","year":"2021","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.aprim.2021.102231_bib0290","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/pde.14523","article-title":"Treatment practices in the management of scabies in infants younger than two months","volume":"38","author":"Thomas","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.aprim.2021.102231_bib0295","doi-asserted-by":"crossref","first-page":"e0008994","DOI":"10.1371\/journal.pntd.0008994","article-title":"Crusted scabies; A 2-year prospective study from the Northern Territory of Australia","volume":"14","author":"Hasan","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.aprim.2021.102231_bib0300","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1017\/S0950268819001249","article-title":"Do we know how scabies outbreaks in residential and nursing care homes for the elderly should be managed? A systematic review of interventions using a novel approach to assess evidence quality","volume":"147","author":"Morrison","year":"2019","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.aprim.2021.102231_bib0305","first-page":"637","article-title":"Control of large institutional scabies outbreaks","volume":"10","author":"Stoevesandt","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.aprim.2021.102231_bib0310","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2133.2000.03704.x","article-title":"The use of ivermectin in controlling an outbreak of scabies in a prison","volume":"143","author":"Leppard","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aprim.2021.102231_bib0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40794-021-00143-5","article-title":"Mass drug administration for endemic scabies: A systematic review","volume":"7","author":"Rinaldi","year":"2021","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"10.1016\/j.aprim.2021.102231_bib0320","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1056\/NEJMc1808439","article-title":"Mass Drug Administration for Scabies - 2 Years of Follow-up","volume":"381","author":"Romani","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656721002651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656721002651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:01:47Z","timestamp":1759323707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656721002651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0212656721002651"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2021.102231","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tratamiento de la escabiosis","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2021.102231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102231"}}